Financial Counseling for Dementia Family Caregivers in Early and Middle Adulthood (FCA 4 FC-EAMA)

June 25, 2026 updated by: Megan Thomas Hebdon, University of Utah

Financial Counseling and Advocacy for Alzheimer's Disease and Related Dementias Family Caregivers in Early and Middle Adulthood

The goal of this National Institutes of Health (NIH) Stage 1a study is to develop and pilot test a research- and community-informed financial counseling and advocacy (FCA) intervention for dementia family caregivers in early and middle adulthood. The main question it aims to answer is:

Is a research- and community-informed financial counseling and advocacy intervention usable, feasible and acceptable for dementia family caregivers in early and middle adulthood?

Participants will engage in a four-week single group financial counseling and advocacy intervention and complete pre- and post-intervention measures addressing financial well-being, caregiver strain, workplace productivity, and flourishing along with usability, acceptability, and feasibility measures.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United States
    • Utah
      • Salt Lake City, Utah, United States, 84112
        • Recruiting
        • University of Utah College of Nursing
        • Contact:
        • Principal Investigator:
          • Megan Thomas Hebdon, PhD, DNP

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Caring for a family member, neighbor, or friend with ADRD
  • Providing care for 20 or more hours per week,
  • Technology access for Zoom visits
  • English speaking

Exclusion Criteria:

  • N/A

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Financial Counseling and Advocacy Arm
Behavioral: Financial Counseling and Advocacy
Financial assessment, coaching, self-advocacy support, referrals, educational toolkit, and follow-up

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of Intervention Measure (FIM)
Time Frame: After intervention completion at 4 weeks
Higher score indicates greater feasibility (Range 4-20)
After intervention completion at 4 weeks
Acceptability of Intervention Measure (AIM)
Time Frame: After intervention completion at 4 weeks
Higher score indicates greater acceptability (Range 4-20)
After intervention completion at 4 weeks
Study Usability
Time Frame: After intervention completion at 4 weeks
Higher score indicates greater usability (Range: 5-25)
After intervention completion at 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Caregiver Strain Index
Time Frame: At baseline and after intervention completion at 4 weeks
Higher score indicates higher caregiver strain (Range: 0-26)
At baseline and after intervention completion at 4 weeks
Workplace Productivity and Activity Impairment
Time Frame: At baseline and after intervention completion at 4 weeks
Higher score indicates greater presenteeism, absenteeism, work productivity loss, and activity impairment (Range: 0-100)
At baseline and after intervention completion at 4 weeks
Consumer Financial Protection Bureau Financial Well-Being Scale
Time Frame: At baseline and after intervention completion at 4 weeks
Higher score indicates greater financial well-being (Range: 0-40)
At baseline and after intervention completion at 4 weeks
Harvard Flourishing Measure
Time Frame: At baseline and after intervention completion at 4 weeks
Higher score indicates greater flourishing in the following domains: Happiness and Life Satisfaction, Mental and Physical Health, Meaning and Purpose, Character and Virtue, and Close Social Relationships, and Financial and Material Stability (Range: 0-10 for each subscale and overall scale score)
At baseline and after intervention completion at 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Utah

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Study Registration Dates

First Submitted

May 5, 2026

First Submitted That Met QC Criteria

June 25, 2026

First Posted (Actual)

July 2, 2026

Study Record Updates

Last Update Posted (Actual)

July 2, 2026

Last Update Submitted That Met QC Criteria

June 25, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB_00185128

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

IPD sharing was not part of the IRB protocol. This is a small scale pilot study, and procedures and findings will be reported in full.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Financial Counseling and Advocacy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe